Discovery of Orally Bioavailable FGFR2/FGFR3 Dual Inhibitors via Structure-Guided Scaffold Repurposing Approach.
ACS Med Chem Lett
; 14(3): 312-318, 2023 Mar 09.
Article
in En
| MEDLINE
| ID: mdl-36923909
Full text:
1
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Year:
2023
Type:
Article